Abpro Holdings ABPO
OTC ABPO
$0.19 -0.02 (-11.26%)
As of: Aug 21, 2026 · 3:37 PM EDT

Abpro Holdings (ABPO) Share-based Compensation (2022 - 2026)

Abpro Holdings' (ABPO) quarterly Share-based Compensation came in at $2.1 million in Q1 2026, up 308.4% YoY from $512000.0 in Q1 2025, and up 531.72% on a QoQ basis from $331000.0 in Q4 2025.

Abpro Holdings (ABPO) Share-based Compensation (2022 - 2026) Analysis & Trends

Abpro Holdings (ABPO) has 5 years of Share-based Compensation data on file, last reported at $2.1 million in Q1 2026.

  • Quarterly Share-based Compensation rose 308.4% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (up 11.46% YoY) and the FY2025 annual result came in at $2.3 million, up 21.22% from the prior year.
  • Share-based Compensation grew to $2.1 million in Q1 2026, from $331000.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $2.3 million in Q4 2023 to a low of $154000.0 in Q2 2025.
  • A 5-year average of $724409.1 and a median of $415000.0 in 2024 frame the typical range for Share-based Compensation.
  • Annual changes were most pronounced in 2024 — Share-based Compensation tumbled 82.82% — and 2026, when it jumped 308.4%.
  • Tracing ABPO's Share-based Compensation over 5 years: stood at $362500.0 in 2022, then soared by 535.86% to $2.3 million in 2023, then plunged by 82.82% to $396000.0 in 2024, then slipped by 16.41% to $331000.0 in 2025, then jumped by 531.72% to $2.1 million in 2026.
  • The last three Share-based Compensation figures came in at $2.1 million (Q1 2026), $331000.0 (Q4 2025), and $286000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 108.10 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 243.00 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 120.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 137.41 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 86.63 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 28.05 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 41.25 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Abpro Holdings 1.14 Mn 1.14 Mn - 208,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 2.09 Mn
Mar 31, 2026 2.09 Mn
Dec 31, 2025 331,000.00
Dec 31, 2025 331,000.00
Sep 30, 2025 286,000.00
Sep 30, 2025 286,000.00
Jun 30, 2025 154,000.00
Jun 30, 2025 154,000.00
Mar 31, 2025 512,000.00
Mar 31, 2025 512,000.00
Dec 31, 2024 396,000.00
Dec 31, 2024 396,000.00
Sep 30, 2024 415,000.00
Sep 30, 2024 415,000.00
Jun 30, 2024 553,000.00
Jun 30, 2024 553,000.00
Mar 31, 2024 563,000.00
Mar 31, 2024 563,000.00
Dec 31, 2023 2.31 Mn
Dec 31, 2023 2.31 Mn